NUMODA PROJECT AGREEMENT FOR PROTOCOL #'s: Lm-LLO-E7-15 and Lm-LLO-E7-07 (Two Trials — TRIAL 1 in India, and TRIAL 2 in the U.S.Project Agreement • June 26th, 2012 • Advaxis, Inc. • Pharmaceutical preparations
Protocol Number: Lm-LLO-E7-15 (conducted in India) Protocol Title: A Randomized, Active Therapy Controlled Phase 2 Study to Assess the Safety and Efficacy of ADXS11-001 with and without Cisplatin as a 2nd Line Therapy for the Treatment of Recurrent Cervical Cancer.
